Sunday, October 25th, 2009
While researching thousands of articles over the last few years in the preparation of my latest book on vitamin C (Levy, 2002), interesting patterns began to emerge. Even though the effects of vitamin C on over 25 different infectious diseases and over 100 different toxins were examined, common mechanisms of action became apparent. This was especially significant to me since I had long wondered how a single chemical entity (ascorbate, or vitamin C) could have such dramatically positive clinical effects on such a wide array of completely unrelated chemical compounds and infectious agents. Quite literally, there More >
(OMNS, October 14, 2009) There was not even one death caused by a vitamin or dietary mineral in 2007, according to the most recent statistics available from the U.S. National Poison Data System. The 132-page annual report of the American Association of Poison Control Centers published in the journal Clinical Toxicology shows zero deaths from multiple vitamins; zero deaths from any of the B vitamins; zero deaths from vitamins A, C, D, or E; and zero deaths from any other vitamin. (1)
Furthermore, there were zero deaths More >
(OMNS) New research confirms that niacinamide, also known as vitamin B-3, is a key to the successful treatment of multiple sclerosis and other nerve diseases.  Niacinamide, say researchers at Harvard Medical School, “profoundly prevents the degeneration of demyelinated axons and improves the behavioral deficits.”
This is very good news, but it is not at all new news. Over 60 years ago, Canadian physician H.T. Mount began treating multiple sclerosis patients with intravenous B-1 (thiamine) plus intramuscular liver extract, which provides other B-vitamins. He followed the progress of these patients for up to 27 years. The results were excellent and More >
NEW YORK (Reuters Health) – Multiple sclerosis (MS) patients who smoke have a speedier progression of the disease, a new study in the Archives of Neurology suggests.
Dr. Alberto Ascherio of the Harvard School of Public Health in Boston and his colleagues also found that smokers with MS were more likely to have the progressive form of the disease, in which symptoms steadily get worse, rather than the relapsing-remitting form, in which a person has MS symptoms intermittently.
“Most of the adverse effects were seen for current smokers, which in some way is good news because it suggests that